| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/04/2002 | US6399610 Nasal or oral treatment of heart failure; reduced occurance of headaches or palpitation |
| 06/04/2002 | US6399112 Chinese herbs extract |
| 06/04/2002 | US6399100 Controlled release pharmaceutical compositions containing tiagabine |
| 05/30/2002 | WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | WO2002041925A1 Sterilisation of pharmaceuticals |
| 05/30/2002 | WO2002041909A1 Method and preparations having effect against allergic symptoms |
| 05/30/2002 | WO2002041908A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | WO2002041828A2 Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon |
| 05/30/2002 | WO2001089463A3 Effervescent whitening dentifrice having sensory signal based on the release or oxygen |
| 05/30/2002 | US20020065319 For use in therapy of schizophrenia and/or tardive dyskinesia |
| 05/30/2002 | US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | US20020065305 As antitumor agent |
| 05/30/2002 | US20020065304 As antitumor agent |
| 05/30/2002 | US20020065263 Formulation |
| 05/30/2002 | US20020064547 Liquid polymeric compositions for controlled release of bioactive substances |
| 05/30/2002 | CA2430113A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/29/2002 | EP1207740A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 05/29/2002 | EP0923382B1 Compositions of plant carbohydrates as dietary supplements |
| 05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
| 05/29/2002 | CN1351606A Halo derivatives of 9-Deoxo-9a-Aza-9a-Homery theromycin A |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351499A Composition pharmaceutique |
| 05/29/2002 | CN1085526C Air pressed package using polyoxyethylene glyceryl oleate |
| 05/29/2002 | CN1085525C Air pressed package using polyoxyethyene glyceryl oleate |
| 05/28/2002 | US6395736 Compositions and methods for the treatment of anorectal disorders |
| 05/28/2002 | US6395313 Ngali nut oil |
| 05/28/2002 | US6395308 For the treatment of asthma bronchiale, colitis ulcerosa, morbus crohn, diseases of the rheumatic type, and indications in which an increase of the lipoxygenase level occurs either by medicaments, other substances or diseases. |
| 05/28/2002 | CA2129855C Pressurized gas packagings using polyoxyethylene glyceryl-oleates |
| 05/23/2002 | WO2002039960A2 Cosmetic method of treating skin |
| 05/23/2002 | WO2002039951A2 Yeast-dentritic cell vaccines and uses thereof |
| 05/23/2002 | WO2002039949A2 Platelet/leukocyte interaction assay and reagent therefor |
| 05/23/2002 | WO2001074394A8 New combination of a betablocker and a cholesterol-lowering agent |
| 05/23/2002 | US20020061917 Efficient process for the preparation of a factor Xa inhibitor |
| 05/23/2002 | US20020061863 Consisting of 4-thiouridine, isomaltitol, and uridine; also for problems in hemostasis related to platelet function or inflammation associated with bacterial infection |
| 05/23/2002 | US20020061540 Library; for use in drug screening and development |
| 05/23/2002 | US20020061341 Treating sexual disorders with benzyl isothiocyanate, Lepidium sterol component, Lepidium fatty acid and a macamide component; cellulose-free |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | CA2428109A1 Platelet/leukocyte interaction assay and reagent therefor |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1005321B1 Hair conditioner and 2-in-1 conditioning shampoo |
| 05/22/2002 | EP0746329B1 Anti-inflammatory factor containing compositions, method of production, and use |
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | CN1350540A Process for preparing amine platinum complexes |
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/21/2002 | US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | US6391876 Reboxetine for treatment obsessive compulsive disorders and panic disorder |
| 05/21/2002 | US6391339 Administering pentasaccharide anticoagulant |
| 05/21/2002 | CA2119932C Pressurized hydrofluoroalkane pharmaceutical aerosol compositions |
| 05/16/2002 | WO2001074341A3 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 05/16/2002 | US20020058634 Formulation of nitrogen mustard |
| 05/16/2002 | US20020058618 Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor |
| 05/16/2002 | US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension. |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1204663A1 Novel spiro compounds |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204413A2 Control of crustacean infestation of aquatic animals |
| 05/15/2002 | EP1161247A4 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/15/2002 | CN1349415A Contraceptive compositions contaiing antiprogesting and progestinic |
| 05/15/2002 | CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity |
| 05/15/2002 | CN1349400A Antiperspirant stick agent |
| 05/15/2002 | CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives |
| 05/14/2002 | US6388092 Antitumor agent |
| 05/14/2002 | US6388077 Spiro compounds |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/14/2002 | US6387886 Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic |
| 05/10/2002 | WO2002036160A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | WO2001072288A3 Use of cdp-choline for the treatment of alcohol withdrawal syndrome |
| 05/10/2002 | CA2427539A1 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/09/2002 | US20020054871 Treating a host suffering from hyperlipidemia resulting from elevated levels of at least one of very low density lipoproteins and triglycerides and effective amount of an agent that reduces the level of active apolipoprotein E |
| 05/09/2002 | US20020053110 Hair coloring compositions |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203574A2 Dentrifice compositions having reduced abrasivity |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/08/2002 | CN1348377A Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/08/2002 | CN1348375A Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 05/08/2002 | CN1348331A Retarding formulations of active substances used for plant protection |
| 05/07/2002 | US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction |
| 05/07/2002 | US6384059 Crystalline form of omeprazole |
| 05/07/2002 | US6383526 Extraction in alcohol of valerenic acid while minimizing valepotriates and valepotriate degradation products; used as sedative, muscle relaxant, or anxiolytic agent |
| 05/07/2002 | CA2223700C In ovo vaccination against coccidiosis |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034211A2 Antiperspirant salts for enhanced cosmetic products |
| 05/02/2002 | WO2001092282A3 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/02/2002 | WO2001089465A3 Emulsions with naphthalate esters |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | US20020052418 Administering a derivative of a valproic acid amide or a 2-valproenic acid amide to the patient for treating pain and headache disorders |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | US20020051800 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP1200128A1 Preserved pharmaceutical formulations |